Key facts for J0587
- Billing unit
- 100 UNITS
- Inj, rimabotulinumtoxinb
- ASP payment limit
- $13.301
- October 2026; +0.1% vs July 2026
- Practitioner MUE
- 300
- MAI 3
- NCCI exposure
- no PTP pairs
- Coverage articles
- 10
- 35 states
TL;DR
HCPCS J0587 is the Level II code for Injection, rimabotulinumtoxinb, 100 units, billed per 100 UNITS. The Medicare Part B ASP payment limit for October 2026 is $13.301 per billing unit, up 0.1% from July 2026. The practitioner MUE allows up to 300 units per date of service (MAI 3), so a full 300-unit day is $3,990.30 at the current limit. Under OPPS it carries status indicator K in APC 9018. J0587 is billed in units of 100 UNITS; the quantity administered, the NDC package and the units on the claim must reconcile, which is the check that prevents CARC 16 and 151 returns on this line. The ASP crosswalk maps 3 NDCs to it, sold as Myobloc by Supernus Pharmaceuticals, Inc. 10 Medicare coverage articles list the code across 29 states plus DC and 5 territories, including A57114.
Medicare Part B payment limit (ASP)
CMS sets the Part B payment limit for J0587 at $13.301 per 100 UNITS for October 2026, derived from manufacturer average sales price plus 6%, compared with $13.287 in July 2026. Beneficiary coinsurance is 20%.
| Quarter | Payment limit | Per | Coinsurance |
|---|---|---|---|
| October 2026 | $13.301 | 100 UNITS | 20% |
| July 2026 | $13.287 | 100 UNITS | — |
NDC to HCPCS billing-unit conversion
The October 2026 ASP crosswalk maps 3 NDCs from 1 labeler to J0587. Report the NDC in the claim's drug segment and bill the number of J0587 units that equals the quantity administered divided by 100 UNITS; the last column gives units per full package.
| NDC | Drug name | Labeler | Package size | Billing units / package |
|---|---|---|---|---|
| 10454-0710-10 | Myobloc | Supernus Pharmaceuticals, Inc. | 0.5 × 1 | 25 |
| 10454-0711-10 | Myobloc | Supernus Pharmaceuticals, Inc. | 1 × 1 | 50 |
| 10454-0712-10 | Myobloc | Supernus Pharmaceuticals, Inc. | 2 × 1 | 100 |
Medically Unlikely Edits (MUE)
CMS publishes 3 MUE values for J0587. For practitioners the limit is 300 units per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.
| Setting | MUE (units/DOS) | MAI | CMS rationale |
|---|---|---|---|
| Practitioner services | 300 | 3 Date of Service Edit: Clinical | Clinical: Data |
| Facility outpatient hospital | 300 | 3 Date of Service Edit: Clinical | Clinical: Data |
| DME supplier | 0 | 3 Date of Service Edit: Clinical | CMS Policy |
MUE for J0587 in every setting opens the lookup with this code filled in, next to any other code on the same claim.
NCCI edits and add-on relationships
No active practitioner PTP pair lists J0587 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.
The counts above are exposure, not answers for a specific claim. Check J0587 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.
J0587 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.
Medicare coverage articles
10 current Medicare Administrative Contractor articles list J0587 in their HCPCS tables, covering 35 states. Each article carries the covered and non-covered ICD-10 codes that medical-necessity denials (CARC 50) are adjudicated against.
| Article | Title | Contractor(s) | States | Related LCD |
|---|---|---|---|---|
| A57114 | Billing and Coding: Trigger Point Injections | First Coast Service Options, Inc. | FL PR VI | L33912 |
| A57185 | Billing and Coding: Botulinum Toxin Injections | Noridian Healthcare Solutions, LLC | AS CA CNMI GU HI NV | L35170 |
| A57186 | Billing and Coding: Botulinum Toxin Injections | Noridian Healthcare Solutions, LLC | AZ MT ND SD UT WY | L35172 |
| A57715 | Billing and Coding: Botulinum Toxins | First Coast Service Options, Inc. | FL PR VI | L33274 |
| A57751 | Billing and Coding: Trigger Point Injections | Novitas Solutions, Inc. | DC DE MD NJ PA | L35010 |
| A58423 | Billing and Coding: Botulinum Toxins | Novitas Solutions, Inc. | DC DE MD NJ PA | L38809, L40016 |
| A59707 | Billing and Coding: Botulinum Toxin Injections | Wellpoint Federal | CT IL MN NY WI | L39832 |
| A59714 | Billing and Coding: Botulinum Toxin Injections | Palmetto GBA | NC SC VA WV | L39836 |
| A59726 | Billing and Coding: Botulinum Toxins Injections | CGS Administrators, LLC | KY OH | L39857 |
| A59809 | Billing and Coding: Botulinum Toxin Injections | Wisconsin Physicians Service Insurance Corporation | IA KS MO NE | L39909, L40381 |
Diagnoses Medicare contractors cover for J0587
8 billing and coding articles attach a covered diagnosis list to J0587: 12 distinct ICD-10-CM codes in all. The 12 below come first by how many of those articles cover them, then in the contractor's own order. The claim line is checked against the list of the contractor that processes it, and a diagnosis outside that list is denied as not medically necessary (CARC 50).
| ICD-10-CM | Description (FY2027) | Articles covering |
|---|---|---|
| G24.3 | Spasmodic torticollis | 8 of 8 |
| K11.7 | Disturbances of salivary secretion | 8 of 8 |
| G24.02 | Drug induced acute dystonia | 6 of 8 |
| G24.09 | Other drug induced dystonia | 6 of 8 |
| G24.1 | Genetic torsion dystonia | 6 of 8 |
| G24.2 | Idiopathic nonfamilial dystonia | 6 of 8 |
| G80.3 | Athetoid cerebral palsy | 6 of 8 |
| M43.6 | Torticollis | 6 of 8 |
| M47.812 | Spondylosis without myelopathy or radiculopathy, cervical region | 6 of 8 |
| M47.892 | Other spondylosis, cervical region | 6 of 8 |
| M54.2 | Cervicalgia | 6 of 8 |
| Q68.0 | Congenital deformity of sternocleidomastoid muscle | 6 of 8 |
Contractors split an article's diagnoses into numbered groups and say in each group's instructions which procedure codes it supports. Only the groups that apply to J0587 are counted here: a group whose instructions name J0587, together with any unnamed groups directly after it, read as continuations of those instructions. The full list opens on the policy page with every group, the non-covered codes and the instructions.
| Article | Contractor | Groups that apply | Covered codes for J0587 | Full list |
|---|---|---|---|---|
| A57114 | First Coast Service Options, Inc. | groups are written for 20552, 20553 | — | On LCD L33912 |
| A57185 | Noridian Healthcare Solutions, LLC | groups 5 and 16 apply to J0587 | 12 | On LCD L35170 |
| A57186 | Noridian Healthcare Solutions, LLC | groups 5 and 16 apply to J0587 | 12 | On LCD L35172 |
| A57715 | First Coast Service Options, Inc. | group 3 applies to J0587 | 2 | On LCD L33274 |
| A57751 | Novitas Solutions, Inc. | groups are written for 20552, 20553 | — | On LCD L35010 |
| A58423 | Novitas Solutions, Inc. | group 3 applies to J0587 | 2 | On LCD L38809 |
| A59707 | Wellpoint Federal | groups 5 and 16 apply to J0587 | 12 | On LCD L39832 |
| A59714 | Palmetto GBA | groups 5 and 16 apply to J0587 | 12 | On LCD L39836 |
| A59726 | CGS Administrators, LLC | groups 5 and 16 apply to J0587 | 12 | On LCD L39857 |
| A59809 | Wisconsin Physicians Service Insurance Corporation | groups 5 and 16 apply to J0587 | 12 | On LCD L39909 |
2 more articles list J0587 but write their diagnosis groups for other procedure codes in the same article; there the diagnosis has to fit the group written for the procedure billed with the drug.
Local coverage policies that list J0587
10 active Local Coverage Determinations list J0587 in the policy or in its billing and coding article. Each applies only in its contractor's jurisdiction; check the one for the state where the drug is administered.
- LCD L35010: Trigger Point Injections · Novitas Solutions, Inc.
- Botulinum Toxins, LCD L38809 · Novitas Solutions, Inc.
- Botulinum Toxin Injections (L39909) · Wisconsin Physicians Service Insurance Corporation
- L33274 Botulinum Toxins · First Coast Service Options, Inc.
- L33912 Trigger Point Injections · First Coast Service Options, Inc.
- L35170 Botulinum Toxin Injections · Noridian Healthcare Solutions, LLC
- L35172 Botulinum Toxin Injections · Noridian Healthcare Solutions, LLC
- L39832 Botulinum Toxin Injections · Wellpoint Federal
- L39836 Botulinum Toxin Injections · Palmetto GBA
- L39857 Botulinum Toxin Injections · CGS Administrators, LLC
Hospital outpatient (OPPS) status
In the October 2026 OPPS Addendum B, J0587 carries status indicator K and is assigned to APC 9018, with a published national unadjusted payment of $13.301. Status K means the drug is paid separately under OPPS at the ASP-based rate rather than packaged into the procedure.
Ambulatory surgical center (ASC) payment
In the October 2026 ASC Addendum BB (covered ancillary services), J0587 carries payment indicator K2, which CMS defines as "Drugs, biologicals, and radiopharmaceuticals paid separately when provided integral to a surgical procedure on ASC list; payment based on OPPS rate". The national ASC payment is $13.30 per 100 UNITS, paid only when the drug is furnished integral to a covered surgical procedure.
Common denials for J0587 and how to prevent them
For teams evaluating QuickIntell software
Evaluate a coding workflow for J0587
Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.
Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.
In QuickIntell research
- J codes by drug name: Every code for the same drug, generic or brand, in one A-Z index.
Frequently asked questions — HCPCS J0587
What does HCPCS code J0587 describe?
J0587 is defined by CMS as "Injection, rimabotulinumtoxinb, 100 units". Each billing unit represents 100 UNITS, so the units reported on the claim must equal the dose administered divided by that unit.
Is J0587 a CPT code?
No. J0587 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as rimabotulinumtoxinb (Myobloc); CPT codes are five-character codes maintained by the AMA. On a Part B claim J0587 reports the drug itself in 100 units units, and the administration is billed on its own line.
What is the Medicare reimbursement for J0587 in October 2026?
The ASP-based payment limit is $13.301 per 100 UNITS, with 20% beneficiary coinsurance. The July 2026 limit was $13.287. Commercial payers use their own fee schedules.
How many units of J0587 can be billed per day?
The practitioner Medically Unlikely Edit is 300 units per date of service with adjudication indicator 3 (Date of Service Edit: Clinical). MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "Clinical: Data" as the rationale.
Which NDCs map to J0587?
The October 2026 ASP crosswalk lists 3 NDCs from 1 labeler: Myobloc (Supernus Pharmaceuticals, Inc.). For example NDC 10454-0710-10 (package size 0.5) equals 25 billing units of J0587.
Does J0587 have NCCI bundling edits?
No active practitioner PTP pairs list J0587 as a column-1 or column-2 code in the v323r0 release.
Which Medicare coverage articles mention J0587?
10 current Billing and Coding Articles in the Medicare Coverage Database list J0587, covering 29 states plus DC and 5 territories: A57114 (Billing and Coding: Trigger Point Injections); A57185 (Billing and Coding: Botulinum Toxin Injections); A57186 (Billing and Coding: Botulinum Toxin Injections).
What diagnosis codes support J0587?
8 Medicare billing and coding articles list 12 covered ICD-10-CM codes for J0587 between them, for example G24.3 (Spasmodic torticollis); K11.7 (Disturbances of salivary secretion); G24.02 (Drug induced acute dystonia); G24.09 (Other drug induced dystonia); G24.1 (Genetic torsion dystonia). Each contractor's list applies only in its own jurisdiction, so the claim must carry a code from the article of the contractor that processes it. 2 more articles tie their diagnosis groups to other procedure codes they list rather than to J0587.
Sources
Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.
- HCPCS Level II alpha-numeric file, October 2026Version October 2026 · effective 2026-10-01 · file HCPC2026_OCT_ANWEB_09232026.txtSHA-256 c25240c63108756d…
- Medicare Part B Drug Payment Limit File, October 2026Version October 2026 · effective 2026-10-01 · file section 508 version of October 2026 Medicare Part B Payment Limit File 091626.csvSHA-256 508fba376a29e099…
- Medicare Part B Drug Payment Limit File, July 2026Version July 2026 · effective 2026-07-01 · file section 508 version of July 2026 Medicare Part B Payment Limit File updated 082026.csvSHA-256 13bb5b644b92b574…
- ASP NDC-HCPCS Crosswalk, October 2026Version October 2026 · effective 2026-10-01 · file section 508 version of October 2026 ASP NDC-HCPCS Crosswalk 091126.csvSHA-256 5cb78f0c2ee786ba…
- NCCI MUE table, practitioner services, effective 2026-10-01Version 2026 Q4 · effective 2026-10-01 · file MCR_MUE_PractitionerServices_Eff_10-01-2026.csvSHA-256 ef038efaf902b7bd…
- NCCI MUE table, facility services, effective 2026-10-01Version 2026 Q4 · effective 2026-10-01 · file MCR_MUE_OutpatientHospitalServices_Eff_10-01-2026.csvSHA-256 3af9f4e99cc587e2…
- NCCI MUE table, dme services, effective 2026-10-01Version 2026 Q4 · effective 2026-10-01 · file MCR_MUE_DMESupplierServices_Eff_10-01-2026.csvSHA-256 6fa4fbba852f7b74…
- NCCI PTP edits, practitioner, v323r0 (four files)Version v323r0 (2026 Q4) · effective 2026-10-01 · file ccipra-v323r0-f1.TXTSHA-256 7793c0b6686c1e22…
- NCCI Add-On Code edits, effective 2026-10-01Version 2026 Q4 · effective 2026-10-01 · file AOC_V2026Q4-F-MCR.xlsxSHA-256 eabb519623134549…
- OPPS Addendum B, October 2026Version October 2026 · effective 2026-10-01 · file 508-compliant-version-2026_October_Web_Addendum_B.09.28.26.csvSHA-256 6ad7393a318bf1b9…
- ASC Addendum BB (covered ancillary services), October 2026Version October 2026 · effective 2026-10-01 · file Oct 2026 ASC BB.txtSHA-256 63cdd7c72aba7a25…
- Medicare Coverage Database, current Billing and Coding Articles exportVersion MCD release 2026-11-12 · effective 2026-11-08 · file article.csvSHA-256 b475751458564786…
- ICD-10-CM FY2027 code descriptionsVersion FY2027 · effective 2026-10-01 · file icd10cm_codes_2027.txtSHA-256 3c0583a38ee0e848…
Disclaimer
This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.
Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.